Invention Grant
- Patent Title: Compositions and methods for predicting response to NaPi2b-targeted therapy
-
Application No.: US16136706Application Date: 2018-09-20
-
Publication No.: US11596694B2Publication Date: 2023-03-07
- Inventor: Rebecca Mosher , Laura L. Poling , Donald A. Bergstrom
- Applicant: Mersana Therapeutics, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Mersana Therapeutics, Inc.
- Current Assignee: Mersana Therapeutics, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Cooley LLP
- Agent Cynthia A. Kozakiewicz; Andrew Henderson
- Main IPC: A61K47/68
- IPC: A61K47/68 ; C07K16/28 ; G01N33/574 ; C07K16/30 ; A61P35/00 ; A61K49/00 ; A61K39/00
Abstract:
This disclosure provides reagents and methods of predicting the responsiveness of a patient to NaPi2b-targeted antibody-drug conjugates (e.g., NaPi2b-targeted antibody-polymer-drug conjugates).
Public/Granted literature
- US20190160181A1 COMPOSITIONS AND METHODS FOR PREDICTING RESPONSE TO NAPI2B-TARGETED THERAPY Public/Granted day:2019-05-30
Information query
IPC分类:
